Taro Receives Patent for Ovide

Taro Pharmaceutical Industries Ltd. announced that the U.S. Patent and Trademark Office has issued a patent covering its Ovide(r) (malathion) lotion, 0.5% (patent no. US 7,560,445).

The details can be read here.